Morning Overview on MSN
Scientists found a new trigger for Alzheimer’s and a drug that appears to shut it down
Researchers at ETH Zurich have identified a previously overlooked protein mechanism that drives mitochondrial failure in ...
According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a ...
Researchers at the University of Münster and Ruhr University Bochum have demonstrated for the first time in real time that the body's own defense cells use catecholamines—neurotransmitters such as ...
Within 400 milliseconds, your brain and face begin responding to another person's smile, setting off a cascade that researchers are only beginning to understand.
Parkinson’s disease is a long-term brain disorder that slowly damages nerve cells involved in movement. It affects millions of people around the world and becomes more common with age. The disease is ...
According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle ...
The findings point to the brain's own communication machinery unknowingly contributing to the spread of the disease.
For nearly two years, Casey Harrell operated a brain-computer interface at home — without any researcher present — to ...
A UCR engineer won a $1.6 million federal grant to improve scientists' ability to interpret brain activity and advance ...
A new study suggests a common brain protein may be enabling Alzheimer’s to spread between neurons through microscopic ...
A common brain protein may be giving Alzheimer’s disease an unexpected way to spread, carrying toxic Tau proteins from ...
Neuropeptides are brain and body signaling molecules that shape emotion, pain, metabolism, cognition, and immune function.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果